Aims: To investigate perceived expressed emotion (EE) and self-esteem in adolescents with primary headaches and to assess the psychologic factors, especially perceived EE, that may play a mediating role in the relationship between pain severity and psychosocial quality of life (QoL).
Methods: The sample of this single-center cross-sectional case-control study consisted of 102 adolescents with migraine without aura, 36 adolescents with tension-type headache (TTH), 62 age- and sex-matched healthy adolescents, and their parents. Perceived EE was evaluated with the Shortened Level of Expressed Emotion Scale (SLEES). The Rosenberg Self-Esteem Scale (RSS) was used to assess the self-esteem of the participants.
Results: There were significant differences in both SLEES (F [2.199] = 7.913, P < .001) and RSS (F [2.199] = 8.138, P < .001) scores between the groups. When the two groups were compared in terms of SLEES score, adolescents with migraine and TTH had significantly higher levels of perceived EE and lower levels of self-esteem than their healthy peers. In mediation analyses, RSS and SLEES scores were found to be partial mediating factors in the relationship between pain severity and psychosocial QoL.
Conclusion: Adolescents with migraine and TTH had higher perceived EE and lower self-esteem than their healthy peers. The most important result of this study was the demonstration that self-esteem and perceived EE can be two factors that play a mediating role in the relationship between headache and psychosocial QoL.
目的:探讨青少年原发性头痛患者的感知情感表达(EE)和自尊,并探讨在疼痛严重程度和心理社会生活质量(QoL)之间可能起中介作用的心理因素,尤其是感知情感表达(EE)。方法:本研究采用单中心横断面病例对照研究,包括102例无先兆偏头痛青少年、36例紧张性头痛青少年、62例年龄和性别匹配的健康青少年及其父母。感知情感表达采用缩短的情绪表达水平量表(SLEES)进行评估。采用罗森博格自尊量表(RSS)评估被试的自尊。结果:两组患者SLEES (F [2.199] = 7.913, P < .001)和RSS (F [2.199] = 8.138, P < .001)评分差异均有统计学意义。当两组在SLEES评分方面进行比较时,偏头痛和TTH青少年的感知情感表达水平显著高于健康同龄人,自尊水平显著低于健康同龄人。在中介分析中,发现RSS和SLEES评分是疼痛严重程度与心理社会生活质量之间关系的部分中介因素。结论:青少年偏头痛和TTH患者的情感表达水平高于健康同龄人,自尊水平较低。本研究最重要的结果是证明自尊和情感表达在头痛与心理社会生活质量的关系中起中介作用。
{"title":"Pain Severity and Psychosocial Quality of Life in Adolescents with Migraine and Tension-Type Headache: Mediation by Perceived Expressed Emotion and Self-Esteem.","authors":"Halit Necmi Uçar, Emine Tekin, Uğur Tekin","doi":"10.11607/ofph.2768","DOIUrl":"https://doi.org/10.11607/ofph.2768","url":null,"abstract":"<p><strong>Aims: </strong>To investigate perceived expressed emotion (EE) and self-esteem in adolescents with primary headaches and to assess the psychologic factors, especially perceived EE, that may play a mediating role in the relationship between pain severity and psychosocial quality of life (QoL).</p><p><strong>Methods: </strong>The sample of this single-center cross-sectional case-control study consisted of 102 adolescents with migraine without aura, 36 adolescents with tension-type headache (TTH), 62 age- and sex-matched healthy adolescents, and their parents. Perceived EE was evaluated with the Shortened Level of Expressed Emotion Scale (SLEES). The Rosenberg Self-Esteem Scale (RSS) was used to assess the self-esteem of the participants.</p><p><strong>Results: </strong>There were significant differences in both SLEES (F [2.199] = 7.913, P < .001) and RSS (F [2.199] = 8.138, P < .001) scores between the groups. When the two groups were compared in terms of SLEES score, adolescents with migraine and TTH had significantly higher levels of perceived EE and lower levels of self-esteem than their healthy peers. In mediation analyses, RSS and SLEES scores were found to be partial mediating factors in the relationship between pain severity and psychosocial QoL.</p><p><strong>Conclusion: </strong>Adolescents with migraine and TTH had higher perceived EE and lower self-esteem than their healthy peers. The most important result of this study was the demonstration that self-esteem and perceived EE can be two factors that play a mediating role in the relationship between headache and psychosocial QoL.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 1","pages":"62-71"},"PeriodicalIF":2.5,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25487051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rodrigo Lorenzi Poluha, Giancarlo De la Torre Canales, Leonardo Rigoldi Bonjardim, Paulo César Rodrigues Conti
Aims: To investigate the effect of masticatory muscle contraction on the pressure pain threshold (PPT) of the lateral pole of the temporomandibular joint (TMJ) in patients with TMJ arthralgia and in asymptomatic individuals.
Methods: A total of 72 individuals divided into two groups (group 1: patients with unilateral TMJ arthralgia [n = 36]; group 2: control group, asymptomatic individuals [n = 36]) were compared. The PPT of the lateral pole of the TMJ with and without concomitant masticatory muscle contraction was determined using a digital algometer in both groups. Paired and independent Student t test were used to compare the data within and between groups, respectively. A 5% significance level was used for all tests.
Results: Higher TMJ PPT values with concomitant masticatory muscle contraction were found in both groups (P < .001). The amount of increase in PPT with contracted muscles was not significantly different between groups (P = .341), but the TMJ arthralgia group had significantly lower PPT values than the control group regardless of muscle contraction status (P < .001).
Conclusion: Concomitant masticatory muscle contraction significantly increased the PPT of the lateral pole of the TMJ in relation to relaxed muscles, regardless of the presence of arthralgia.
{"title":"Can Concomitant Masticatory Muscle Contraction Interfere with Temporomandibular Joint Arthralgia Evaluation?","authors":"Rodrigo Lorenzi Poluha, Giancarlo De la Torre Canales, Leonardo Rigoldi Bonjardim, Paulo César Rodrigues Conti","doi":"10.11607/ofph.2759","DOIUrl":"https://doi.org/10.11607/ofph.2759","url":null,"abstract":"<p><strong>Aims: </strong>To investigate the effect of masticatory muscle contraction on the pressure pain threshold (PPT) of the lateral pole of the temporomandibular joint (TMJ) in patients with TMJ arthralgia and in asymptomatic individuals.</p><p><strong>Methods: </strong>A total of 72 individuals divided into two groups (group 1: patients with unilateral TMJ arthralgia [n = 36]; group 2: control group, asymptomatic individuals [n = 36]) were compared. The PPT of the lateral pole of the TMJ with and without concomitant masticatory muscle contraction was determined using a digital algometer in both groups. Paired and independent Student t test were used to compare the data within and between groups, respectively. A 5% significance level was used for all tests.</p><p><strong>Results: </strong>Higher TMJ PPT values with concomitant masticatory muscle contraction were found in both groups (P < .001). The amount of increase in PPT with contracted muscles was not significantly different between groups (P = .341), but the TMJ arthralgia group had significantly lower PPT values than the control group regardless of muscle contraction status (P < .001).</p><p><strong>Conclusion: </strong>Concomitant masticatory muscle contraction significantly increased the PPT of the lateral pole of the TMJ in relation to relaxed muscles, regardless of the presence of arthralgia.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 1","pages":"72-76"},"PeriodicalIF":2.5,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25487053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fernanda Pereira de Caxias, Fernando Gustavo Exposto, Karina Helga Leal Turcio, Daniela Micheline Dos Santos, Peter Svensson
Aims: To investigate whether localized sensitization of the sternocleidomastoid (SCM) muscle using nerve growth factor (NGF) would affect masseter and anterior temporalis muscle sensitivity and pain profiles.
Methods: A total of 28 healthy participants attended two sessions (T0 and T1). At T0, the maximum voluntary occlusal bite force (MVOBF), as well as pressure pain thresholds (PPT), mechanical sensitivity, and referred pain/sensations for the SCM, masseter, and temporalis muscles, were assessed. Participants also completed the Pain Catastrophizing Scale (PCS), the Pain Vigilance and Awareness Questionnaire (PVAQ), and the Neck Disability Index (NDI). After these assessments, 14 participants received an injection of NGF into the SCM, and 14 received an injection of isotonic saline solution. At T1 (48 hours postinjection), the participants were again submitted to the same evaluations.
Results: NGF caused significant mechanical sensitization in the SCM (P < .025), but not in the masseter or temporalis muscles (P > .208). It also caused significant increases in NDI score (P = .004). No statistically significant differences were found for MVOBF, frequency of referred pain/sensations, or questionnaire scores (P > .248).
Conclusion: These results suggest that 48 hours after localized sensitization of the SCM, the primary response is impairment of neck function, but not jaw function.
{"title":"Nerve Growth Factor-Induced Sensitization of the Sternocleidomastoid Muscle and Its Effects on Trigeminal Muscle Sensitivity and Pain Profiles: A Randomized Double-Blind Controlled Study.","authors":"Fernanda Pereira de Caxias, Fernando Gustavo Exposto, Karina Helga Leal Turcio, Daniela Micheline Dos Santos, Peter Svensson","doi":"10.11607/ofph.2593","DOIUrl":"https://doi.org/10.11607/ofph.2593","url":null,"abstract":"<p><strong>Aims: </strong>To investigate whether localized sensitization of the sternocleidomastoid (SCM) muscle using nerve growth factor (NGF) would affect masseter and anterior temporalis muscle sensitivity and pain profiles.</p><p><strong>Methods: </strong>A total of 28 healthy participants attended two sessions (T<sub>0</sub> and T<sub>1</sub>). At T<sub>0</sub>, the maximum voluntary occlusal bite force (MVOBF), as well as pressure pain thresholds (PPT), mechanical sensitivity, and referred pain/sensations for the SCM, masseter, and temporalis muscles, were assessed. Participants also completed the Pain Catastrophizing Scale (PCS), the Pain Vigilance and Awareness Questionnaire (PVAQ), and the Neck Disability Index (NDI). After these assessments, 14 participants received an injection of NGF into the SCM, and 14 received an injection of isotonic saline solution. At T<sub>1</sub> (48 hours postinjection), the participants were again submitted to the same evaluations.</p><p><strong>Results: </strong>NGF caused significant mechanical sensitization in the SCM (P < .025), but not in the masseter or temporalis muscles (P > .208). It also caused significant increases in NDI score (P = .004). No statistically significant differences were found for MVOBF, frequency of referred pain/sensations, or questionnaire scores (P > .248).</p><p><strong>Conclusion: </strong>These results suggest that 48 hours after localized sensitization of the SCM, the primary response is impairment of neck function, but not jaw function.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 1","pages":"7-16"},"PeriodicalIF":2.5,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25487081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eva Leksell, Catharina Eriksson, Malin Ernberg, Britt Hedenberg-Magnusson
Aims: (1) To deepen knowledge on how specialized health care professionals (HCPs) reflect on encounters with children diagnosed with juvenile idiopathic arthritis (JIA) and (2) to outline a theory for orofacial care.
Methods: Grounded theory was used to discover the psychosocial processes involved in communication between HCPs, children, and parents, and this information was used to develop a theory about these processes. Using classic grounded theory, a total of 20 interviews with HCPs were analyzed.
Results: One main concern, "secure health and biopsychosocial development," permeated all care. A core category was identified as "create a responsive interaction with the child and family." The data that supported this core category helped to explain how the HCP responded to a patient to promote orofacial health. Based on the dentist's responses to the child, eight subcategories were identified: (1) secure confidential relationships; (2) convey disease-specific knowledge; (3) communicate healthy findings and form mutual insights at examination; (4) encourage health-promoting behaviors; (5) ensure follow-up; (6) share perspectives; (7) guide parenting; and (8) improve knowledge and networks.
Conclusion: How the dentist shall best understand the needs of a child diagnosed with JIA requires further evaluation. To promote oral health, the child must feel safe, confirmed, and supported with knowledge. Also, further studies are needed on the dentist's collaboration with the pediatrician and the physiotherapist for contributing to overall health.
{"title":"Facilitating Care of Children with Juvenile Idiopathic Arthritis, Orofacial Pain, and Dysfunction: An Interview Study of Specialized Health Professionals.","authors":"Eva Leksell, Catharina Eriksson, Malin Ernberg, Britt Hedenberg-Magnusson","doi":"10.11607/ofph.2850","DOIUrl":"https://doi.org/10.11607/ofph.2850","url":null,"abstract":"<p><strong>Aims: </strong>(1) To deepen knowledge on how specialized health care professionals (HCPs) reflect on encounters with children diagnosed with juvenile idiopathic arthritis (JIA) and (2) to outline a theory for orofacial care.</p><p><strong>Methods: </strong>Grounded theory was used to discover the psychosocial processes involved in communication between HCPs, children, and parents, and this information was used to develop a theory about these processes. Using classic grounded theory, a total of 20 interviews with HCPs were analyzed.</p><p><strong>Results: </strong>One main concern, \"secure health and biopsychosocial development,\" permeated all care. A core category was identified as \"create a responsive interaction with the child and family.\" The data that supported this core category helped to explain how the HCP responded to a patient to promote orofacial health. Based on the dentist's responses to the child, eight subcategories were identified: (1) secure confidential relationships; (2) convey disease-specific knowledge; (3) communicate healthy findings and form mutual insights at examination; (4) encourage health-promoting behaviors; (5) ensure follow-up; (6) share perspectives; (7) guide parenting; and (8) improve knowledge and networks.</p><p><strong>Conclusion: </strong>How the dentist shall best understand the needs of a child diagnosed with JIA requires further evaluation. To promote oral health, the child must feel safe, confirmed, and supported with knowledge. Also, further studies are needed on the dentist's collaboration with the pediatrician and the physiotherapist for contributing to overall health.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 4","pages":"278-287"},"PeriodicalIF":2.5,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39651185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To evaluate the association between clinical signs/symptoms and bone changes on CBCT images in patients with degenerative joint disease (DJD) of the temporomandibular joint (TMJ).
Methods: An electronic literature search of the MEDLINE, PubMed, EMBASE, Scopus, and Web of Science databases, as well as Google Scholar for gray literature, was conducted to identify relevant articles on February 26, 2021. Risk of bias was evaluated using the Joanna Briggs Institute critical appraisal tools. The GRADEpro (Recommendation, Assessment, Development, and Evaluation) system instrument was applied to assess the level of evidence across studies.
Results: Nine papers assessing clinical signs/symptoms and CBCT findings were included. TMJ pain (arthralgia) and TMJ noises carried the strongest associations with various CBCT findings, each of which were supported by four studies with significant associations. Only one study found significant associations between masticatory myalgia (muscle pain) and CBCT findings. Range of motion carried no significant associations with CBCT findings in the included studies. Based on the GRADEpro system, the certainty of evidence is low for said associations.
Conclusion: The results suggest that TMD patients with TMJ arthralgia and joint noises may benefit from CBCT imaging. There would be less benefit in TMD patients exhibiting primarily myalgia or limited range of motion, and therefore these patients should not be prescribed routine CBCT radiographs unless indicated by other clinical findings. The heterogeneity of reporting in the included studies suggests that embracing universal clinical (DC/TMD) and radiographic diagnostic criteria for TMJ-DJD would benefit both research and clinical outcomes.
目的:探讨颞下颌关节(TMJ)退行性关节病(DJD)患者的临床体征/症状与CBCT图像上骨骼变化的关系。方法:对MEDLINE、PubMed、EMBASE、Scopus和Web of Science数据库以及Google Scholar的灰色文献进行电子文献检索,确定2021年2月26日的相关文章。使用乔安娜布里格斯研究所的关键评估工具评估偏倚风险。GRADEpro(推荐、评估、发展和评价)系统工具用于评估所有研究的证据水平。结果:纳入了9篇评估临床体征/症状和CBCT表现的论文。TMJ疼痛(关节痛)和TMJ噪音与各种CBCT结果的相关性最强,每种结果都得到了四项具有显著相关性的研究的支持。只有一项研究发现咀嚼肌痛(肌肉疼痛)与CBCT结果之间存在显著关联。在纳入的研究中,活动范围与CBCT结果无显著关联。基于GRADEpro系统,上述关联的证据确定性较低。结论:CBCT对伴有颞颌关节痛和关节噪声的TMD患者有一定的临床价值。对于主要表现为肌痛或活动范围有限的TMD患者,疗效较小,因此除非有其他临床表现,否则这些患者不应进行常规CBCT x线检查。纳入研究报告的异质性表明,采用通用临床(DC/TMD)和放射学诊断标准对TMJ-DJD将有利于研究和临床结果。
{"title":"A Systematic Review on the Association Between Clinical Symptoms and CBCT Findings in Symptomatic TMJ Degenerative Joint Disease.","authors":"Michael Wu, Fabiana T Almeida, Reid Friesen","doi":"10.11607/ofph.2953","DOIUrl":"https://doi.org/10.11607/ofph.2953","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the association between clinical signs/symptoms and bone changes on CBCT images in patients with degenerative joint disease (DJD) of the temporomandibular joint (TMJ).</p><p><strong>Methods: </strong>An electronic literature search of the MEDLINE, PubMed, EMBASE, Scopus, and Web of Science databases, as well as Google Scholar for gray literature, was conducted to identify relevant articles on February 26, 2021. Risk of bias was evaluated using the Joanna Briggs Institute critical appraisal tools. The GRADEpro (Recommendation, Assessment, Development, and Evaluation) system instrument was applied to assess the level of evidence across studies.</p><p><strong>Results: </strong>Nine papers assessing clinical signs/symptoms and CBCT findings were included. TMJ pain (arthralgia) and TMJ noises carried the strongest associations with various CBCT findings, each of which were supported by four studies with significant associations. Only one study found significant associations between masticatory myalgia (muscle pain) and CBCT findings. Range of motion carried no significant associations with CBCT findings in the included studies. Based on the GRADEpro system, the certainty of evidence is low for said associations.</p><p><strong>Conclusion: </strong>The results suggest that TMD patients with TMJ arthralgia and joint noises may benefit from CBCT imaging. There would be less benefit in TMD patients exhibiting primarily myalgia or limited range of motion, and therefore these patients should not be prescribed routine CBCT radiographs unless indicated by other clinical findings. The heterogeneity of reporting in the included studies suggests that embracing universal clinical (DC/TMD) and radiographic diagnostic criteria for TMJ-DJD would benefit both research and clinical outcomes.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 4","pages":"332-345"},"PeriodicalIF":2.5,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39667307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To highlight and discuss the term "refractory" when used to describe pain conditions and its application to orofacial pain, as well as to highlight the factors that must be considered in a refractory patient.
Methods: A scoping review of recent publications (2010 to 2021) applying the term "refractory" to orofacial pain was conducted, and this paper presents their limitations and definitions.
Results: The term "refractory" is often used to describe pain instead of "persistent" or "nonresponsive." There are clear definitions in the use of refractory for migraine, cluster headaches, and other nonheadache disorders. Currently, the term is applied to pain conditions in order to alter the patient pathway of treatment, sometimes to escalate a patient from one care sector to another and sometimes to escalate treatment to more costly surgical interventional techniques.
Conclusion: There is a need for a clear definition for use of the term "refractory" in orofacial pain conditions, excluding migraine and cluster headaches. In addition, there is a requirement for a consensus on the implications of the use of refractory when assessing and managing patients.
{"title":"Refractory Orofacial Pain: Is It the Patient or the Pain?","authors":"Tara Renton","doi":"10.11607/ofph.3009","DOIUrl":"https://doi.org/10.11607/ofph.3009","url":null,"abstract":"<p><strong>Aims: </strong>To highlight and discuss the term \"refractory\" when used to describe pain conditions and its application to orofacial pain, as well as to highlight the factors that must be considered in a refractory patient.</p><p><strong>Methods: </strong>A scoping review of recent publications (2010 to 2021) applying the term \"refractory\" to orofacial pain was conducted, and this paper presents their limitations and definitions.</p><p><strong>Results: </strong>The term \"refractory\" is often used to describe pain instead of \"persistent\" or \"nonresponsive.\" There are clear definitions in the use of refractory for migraine, cluster headaches, and other nonheadache disorders. Currently, the term is applied to pain conditions in order to alter the patient pathway of treatment, sometimes to escalate a patient from one care sector to another and sometimes to escalate treatment to more costly surgical interventional techniques.</p><p><strong>Conclusion: </strong>There is a need for a clear definition for use of the term \"refractory\" in orofacial pain conditions, excluding migraine and cluster headaches. In addition, there is a requirement for a consensus on the implications of the use of refractory when assessing and managing patients.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 4","pages":"317-325"},"PeriodicalIF":2.5,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39667305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dentistry and specifically orofacial pain have been involved in the science of sleep and its interactions with pain and various other relevant disorders for decades. Yet we have not yet explored dreams; an amazing phenomenon occurring during sleep where brain activity can induce a virtual reality that includes visual, auditory, olfactory, taste, and emotional experiences as true as their waketime counterparts. Humans spend about 2 hours dreaming per night, and we have established that most, but not all, of our dreaming occurs during REM (rapid eye movement) sleep. While neuroscientists routinely examine neural activity during sleep, capturing dreams so that they can be evaluated presents obvious challenges. There is general agreement about what dreams are, but ongoing debate remains over why we dream. We may dream to augment rest and repair for our mind and body. We may dream for psychologic reasons. In fact, there are several dream theories, from Sigmund Freud’s interpretations to hypotheses that claim dreams are just random. Many of the theories on the function of dreams are contradicted by the sparse, hallucinatory, and narrative nature of dreams, a nature that seems to lack any specific function; the answer to why we dream remains nebulous. The recent advent of deep neural networks (DNNs) has provided a novel conceptual framework within which to understand the evolved function of dreams1—fascinating, but beyond the scope of this editorial. Dreams, it seems, are not just “sleep-time” entertainment. Dreams can provide much information about our state of mind, problems, and wishes for our future. Answers to our problems may be found in our dreams, which may also try to offer solutions.2 The “dream machine” works efficiently, with insights and “advice” occurring the night of and about a week after a triggering event. This would suggest that dreams serve social and emotional adaptive functions. Would this include pain-related disorders? A relevant question is: Does pain occur in dreams? It has been shown that realistic, localized painful sensations can be experienced in dreams, either through direct incorporation or from past memories. Nevertheless, the frequency of pain dreams in healthy subjects is low. In one study, dreams often reflected attempts to obtain pain relief.3 So although pain is rare in dreams, it is compatible with the representational code of dreaming.3 Patients suffering from burn pain dream more frequently of pain than controls.4 Findings have indicated that dreaming about pain may be an added stress for pain patients and may contribute to both poor sleep and higher pain intensity, which could evolve into a cycle of pain–anxiety–sleeplessness.4 Researchers have found that during dreams in REM sleep, our stress responses shut down, and the neurochemicals responsible for stressful feelings stop being released.5 In addition to this, REM helps reduce the negative effects of difficult memories. Although not studied, this suggests to
{"title":"Editorial: “The stuff that dreams are made of”","authors":"R. Benoliel","doi":"10.11607/ofph.2021.4.e","DOIUrl":"https://doi.org/10.11607/ofph.2021.4.e","url":null,"abstract":"Dentistry and specifically orofacial pain have been involved in the science of sleep and its interactions with pain and various other relevant disorders for decades. Yet we have not yet explored dreams; an amazing phenomenon occurring during sleep where brain activity can induce a virtual reality that includes visual, auditory, olfactory, taste, and emotional experiences as true as their waketime counterparts. Humans spend about 2 hours dreaming per night, and we have established that most, but not all, of our dreaming occurs during REM (rapid eye movement) sleep. While neuroscientists routinely examine neural activity during sleep, capturing dreams so that they can be evaluated presents obvious challenges. There is general agreement about what dreams are, but ongoing debate remains over why we dream. We may dream to augment rest and repair for our mind and body. We may dream for psychologic reasons. In fact, there are several dream theories, from Sigmund Freud’s interpretations to hypotheses that claim dreams are just random. Many of the theories on the function of dreams are contradicted by the sparse, hallucinatory, and narrative nature of dreams, a nature that seems to lack any specific function; the answer to why we dream remains nebulous. The recent advent of deep neural networks (DNNs) has provided a novel conceptual framework within which to understand the evolved function of dreams1—fascinating, but beyond the scope of this editorial. Dreams, it seems, are not just “sleep-time” entertainment. Dreams can provide much information about our state of mind, problems, and wishes for our future. Answers to our problems may be found in our dreams, which may also try to offer solutions.2 The “dream machine” works efficiently, with insights and “advice” occurring the night of and about a week after a triggering event. This would suggest that dreams serve social and emotional adaptive functions. Would this include pain-related disorders? A relevant question is: Does pain occur in dreams? It has been shown that realistic, localized painful sensations can be experienced in dreams, either through direct incorporation or from past memories. Nevertheless, the frequency of pain dreams in healthy subjects is low. In one study, dreams often reflected attempts to obtain pain relief.3 So although pain is rare in dreams, it is compatible with the representational code of dreaming.3 Patients suffering from burn pain dream more frequently of pain than controls.4 Findings have indicated that dreaming about pain may be an added stress for pain patients and may contribute to both poor sleep and higher pain intensity, which could evolve into a cycle of pain–anxiety–sleeplessness.4 Researchers have found that during dreams in REM sleep, our stress responses shut down, and the neurochemicals responsible for stressful feelings stop being released.5 In addition to this, REM helps reduce the negative effects of difficult memories. Although not studied, this suggests to ","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"1 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90471710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: To evaluate the efficacy of intravenous preemptive analgesia on postoperative pain in children undergoing dental rehabilitation under general anesthesia.
Methods: In this prospective randomized clinical trial, 70 children aged 3 to 7 years were scheduled for dental treatment and randomized into two groups: the control group or the preemptive group. Patients received 15 mg/kg of intravenous paracetamol either before the start of treatment (preemptive group, n = 35) or at the end of treatment (control group, n = 35). Postoperative pain scores were recorded at 1, 2, 4, 6, 8, 12, and 24 hours using the Wong-Baker FACES Pain Rating Scale (WBFS). Additionally, the need for rescue analgesic and the total opioid consumption of the patients were recorded during the first 24 hours postoperative.
Results: The pain scores in the preemptive group were significantly lower than those in the control group at the postanesthesia care unit and at 2, 4, and 8 hours postoperative (P < .05). However, there were no statistically significant differences in pain scores between groups at 12 and 24 hours postoperative. Need for rescue analgesics and total intravenous fentanyl consumption were significantly higher in the control group than in the preemptive group (P < .05). The percentage of children who received medication for pain relief at home was higher in the control group than in the preemptive group, but the difference was not statistically significant (P > .05).
Conclusion: Preemptive use of intravenous paracetamol reduces postoperative pain scores and postoperative opioid consumption. However, there is a need to evaluate pain levels in children who receive comprehensive dental treatment under general anesthesia after hospital discharge for effective postoperative pain control.
{"title":"Efficacy of Preemptive Analgesia on Postoperative Pain Control in Children Who Underwent Full-Mouth Dental Rehabilitation Under General Anesthesia: A Randomized Controlled Clinical Trial.","authors":"Sultan Keles, Ozlem Kocaturk, Pinar Demir","doi":"10.11607/ofph.2960","DOIUrl":"https://doi.org/10.11607/ofph.2960","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the efficacy of intravenous preemptive analgesia on postoperative pain in children undergoing dental rehabilitation under general anesthesia.</p><p><strong>Methods: </strong>In this prospective randomized clinical trial, 70 children aged 3 to 7 years were scheduled for dental treatment and randomized into two groups: the control group or the preemptive group. Patients received 15 mg/kg of intravenous paracetamol either before the start of treatment (preemptive group, n = 35) or at the end of treatment (control group, n = 35). Postoperative pain scores were recorded at 1, 2, 4, 6, 8, 12, and 24 hours using the Wong-Baker FACES Pain Rating Scale (WBFS). Additionally, the need for rescue analgesic and the total opioid consumption of the patients were recorded during the first 24 hours postoperative.</p><p><strong>Results: </strong>The pain scores in the preemptive group were significantly lower than those in the control group at the postanesthesia care unit and at 2, 4, and 8 hours postoperative (P < .05). However, there were no statistically significant differences in pain scores between groups at 12 and 24 hours postoperative. Need for rescue analgesics and total intravenous fentanyl consumption were significantly higher in the control group than in the preemptive group (P < .05). The percentage of children who received medication for pain relief at home was higher in the control group than in the preemptive group, but the difference was not statistically significant (P > .05).</p><p><strong>Conclusion: </strong>Preemptive use of intravenous paracetamol reduces postoperative pain scores and postoperative opioid consumption. However, there is a need to evaluate pain levels in children who receive comprehensive dental treatment under general anesthesia after hospital discharge for effective postoperative pain control.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"34 4","pages":"297-302"},"PeriodicalIF":2.5,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39651187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mustafa Sami Demirsoy, Aras Erdil, Mehmet Kemal Tümer
Aims: To investigate the effectiveness of the auriculotemporal nerve block (ATNB) technique in conjunction with noninvasive therapies for the treatment of disc displacement with reduction (DDWR) or without reduction (DDWOR) in addition to arthralgia of the temporomandibular joint (TMJ).
Methods: The data of 22 patients diagnosed with DDWR and DDWOR whose clinical conditions did not improve despite noninvasive treatments were analyzed. ATNB was applied to each patient during the first visit and readministered at 1- and 4-week follow-up visits. Pain intensity values (0 to 10 visual analog scale [VAS] scores) were evaluated pre-ATNB and at the 6-month follow-up visit, and the maximal mouth opening values were measured pre-ATNB and at the 1-week, 4-week, and 6-month follow-up visits.
Results: Noninvasive therapies did not make a significant difference in the outcomes between the initial visit and first administration of ATNB (VAS P = .913, MMO P = .151). However, there were significant differences in outcomes between pre-ATNB and the 1-week (MMO P = .000), 4-week (MMO P = .000), and 6-month (VAS P = .027, MMO P = .000) follow-ups.
Conclusion: ATNB may be considered as a supportive treatment approach in noninvasive TMJ disorder therapies.
目的:探讨耳颞神经阻滞(ATNB)技术联合无创治疗颞下颌关节(TMJ)关节痛伴椎间盘移位复位(DDWR)或不复位(DDWOR)的疗效。方法:对22例经无创治疗后无明显改善的DDWR和DDWOR患者的临床资料进行分析。每位患者在第一次访问时应用ATNB,并在1周和4周随访时重新给予。在atnb前和随访6个月时评估疼痛强度值(0 ~ 10视觉模拟量表[VAS]评分),并在atnb前和随访1周、4周和6个月时测量最大开口值。结果:无创治疗在首次就诊和首次给药ATNB之间的结果无显著差异(VAS P = 0.913, MMO P = 0.151)。然而,atnb前与1周(MMO P = 0.000)、4周(MMO P = 0.000)和6个月(VAS P = 0.027, MMO P = 0.000)随访的结果存在显著差异。结论:ATNB可作为无创治疗颞下颌关节紊乱的一种辅助治疗方法。
{"title":"Evaluation of the Efficacy of Auriculotemporal Nerve Block in Temporomandibular Disorders.","authors":"Mustafa Sami Demirsoy, Aras Erdil, Mehmet Kemal Tümer","doi":"10.11607/ofph.2949","DOIUrl":"https://doi.org/10.11607/ofph.2949","url":null,"abstract":"<p><strong>Aims: </strong>To investigate the effectiveness of the auriculotemporal nerve block (ATNB) technique in conjunction with noninvasive therapies for the treatment of disc displacement with reduction (DDWR) or without reduction (DDWOR) in addition to arthralgia of the temporomandibular joint (TMJ).</p><p><strong>Methods: </strong>The data of 22 patients diagnosed with DDWR and DDWOR whose clinical conditions did not improve despite noninvasive treatments were analyzed. ATNB was applied to each patient during the first visit and readministered at 1- and 4-week follow-up visits. Pain intensity values (0 to 10 visual analog scale [VAS] scores) were evaluated pre-ATNB and at the 6-month follow-up visit, and the maximal mouth opening values were measured pre-ATNB and at the 1-week, 4-week, and 6-month follow-up visits.</p><p><strong>Results: </strong>Noninvasive therapies did not make a significant difference in the outcomes between the initial visit and first administration of ATNB (VAS P = .913, MMO P = .151). However, there were significant differences in outcomes between pre-ATNB and the 1-week (MMO P = .000), 4-week (MMO P = .000), and 6-month (VAS P = .027, MMO P = .000) follow-ups.</p><p><strong>Conclusion: </strong>ATNB may be considered as a supportive treatment approach in noninvasive TMJ disorder therapies.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 4","pages":"326-331"},"PeriodicalIF":2.5,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39667306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria Hietaharju, Ritva Näpänkangas, Kirsi Sipilä, Tuija Teerijoki-Oksa, Johanna Tanner, Pentti Kemppainen, Mimmi Tolvanen, Tuija Suvinen
Aims: To compare the suitability of Graded Chronic Pain Scale (GCPS) pain intensity and interference assessments (GCPS version 1.0 vs 2.0) for the biopsychosocial screening and subtyping of Finnish tertiary care referral patients with TMD pain.
Methods: Altogether, 197 TMD pain patients participated in this study. All patients received Axis II specialist-level psychosocial questionnaires from the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD-FIN) and Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD-FIN), as well as questionnaires for the assessment of additional pain-related, biopsychosocial, and treatment-related variables. Clinical examinations were performed according to the DC/TMD Axis I protocol. The patients were categorized into TMD subtypes 1, 2, and 3 (GCPS I and II-low; II-high; and III and IV, respectively) based on their biopsychosocial profiles according to GCPS versions 1.0 and 2.0.
Results: The distribution of TMD pain patients into TMD subtypes was similar according to the GCPS 1.0 compared to the GCPS 2.0. Over 50% of the patients were moderately (TMD subtype 2) or severely (TMD subtype 3) compromised. Patients in subtype 3 experienced biopsychosocial symptoms and reported previous health care visits significantly more often than patients in subtypes 1 and 2. Patients in subtype 2 reported intermediate biopsychosocial burden compared to subtypes 1 and 3.
Conclusion: TMD pain patients differ in their biopsychosocial profiles, and, similarly to the GCPS 1.0, the GCPS 2.0 is a suitable instrument for categorizing TMD tertiary care pain patients into three biopsychosocially relevant TMD subtypes. The GCPS 2.0 can be regarded as a suitable initial screening tool for adjunct personalized or comprehensive multidisciplinary assessment.
{"title":"Importance of the Graded Chronic Pain Scale as a Biopsychosocial Screening Instrument in TMD Pain Patient Subtyping.","authors":"Maria Hietaharju, Ritva Näpänkangas, Kirsi Sipilä, Tuija Teerijoki-Oksa, Johanna Tanner, Pentti Kemppainen, Mimmi Tolvanen, Tuija Suvinen","doi":"10.11607/ofph.2983","DOIUrl":"https://doi.org/10.11607/ofph.2983","url":null,"abstract":"<p><strong>Aims: </strong>To compare the suitability of Graded Chronic Pain Scale (GCPS) pain intensity and interference assessments (GCPS version 1.0 vs 2.0) for the biopsychosocial screening and subtyping of Finnish tertiary care referral patients with TMD pain.</p><p><strong>Methods: </strong>Altogether, 197 TMD pain patients participated in this study. All patients received Axis II specialist-level psychosocial questionnaires from the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD-FIN) and Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD-FIN), as well as questionnaires for the assessment of additional pain-related, biopsychosocial, and treatment-related variables. Clinical examinations were performed according to the DC/TMD Axis I protocol. The patients were categorized into TMD subtypes 1, 2, and 3 (GCPS I and II-low; II-high; and III and IV, respectively) based on their biopsychosocial profiles according to GCPS versions 1.0 and 2.0.</p><p><strong>Results: </strong>The distribution of TMD pain patients into TMD subtypes was similar according to the GCPS 1.0 compared to the GCPS 2.0. Over 50% of the patients were moderately (TMD subtype 2) or severely (TMD subtype 3) compromised. Patients in subtype 3 experienced biopsychosocial symptoms and reported previous health care visits significantly more often than patients in subtypes 1 and 2. Patients in subtype 2 reported intermediate biopsychosocial burden compared to subtypes 1 and 3.</p><p><strong>Conclusion: </strong>TMD pain patients differ in their biopsychosocial profiles, and, similarly to the GCPS 1.0, the GCPS 2.0 is a suitable instrument for categorizing TMD tertiary care pain patients into three biopsychosocially relevant TMD subtypes. The GCPS 2.0 can be regarded as a suitable initial screening tool for adjunct personalized or comprehensive multidisciplinary assessment.</p>","PeriodicalId":48800,"journal":{"name":"Journal of Oral & Facial Pain and Headache","volume":"35 4","pages":"303-316"},"PeriodicalIF":2.5,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39651188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}